October 13 is Metastatic Breast Cancer Awareness Day. As of 2020, approximately 168,000 women in the U.S. were living with metastatic breast cancer (mBC), which is a projected 31% increase from 2010. This type of cancer, also called stage IV or advanced breast cancer, means it has metastasized, or spread, to other areas in the body such as the liver, lungs, brain, or bones.

Breast cancer vaccines are a buzzy topic that’s seemingly everywhere lately—from ongoing news stories about cancer research to Reddit threads and personalized Instagram posts. But what I’m most interested in knowing is if these vaccines are truly the “golden goose” every woman like me, who is dealing with a breast cancer diagnosis or the aftermath of one, is looking for: can these vaccines truly alleviate my fear by ensuring zero recurrences? To find out, I did a deep dive into the latest information and here’s what I learned.

In 2017, Dawn received her own life-changing diagnosis: triple-negative breast cancer (TNBC), an aggressive form of breast cancer. When diagnosed with this type of breast cancer, the message of hope is often lost amidst the urgency of treating an aggressive form of cancer. Being told things like, “survival rate is low, recurrence is high”, “it’s harder to treat", "chemotherapy regimen is very aggressive”, “the side effects are quite harsh”, “typically, the cancer may return in the first 5 years following treatment” can leave a person feeling helpless.

The world of cancer treatment is rapidly advancing. Scientists are discovering new ways to target cancers, making drugs more effective and more precise. But with these new advancements, comes a long process of approvals involving many steps to allow Canadians to access them. Not only do new drugs need to be approved for safety and efficacy by regulatory bodies like Health Canada and the Canadian Drug Agency, but then they also need to go through price negotiations between the drug manufacturers and the provinces . These negotiations set the cost that every province will pay to the drug company once the drug is added to public drug plans.

Driven by a profound commitment to community service and making a meaningful impact, Chhavi is passionate about leveraging her skills and experience to support non-profit initiatives, especially those focused on breast cancer awareness and support. Her journey with hormone-positive stage II breast cancer in 2023 has profoundly shaped her heartfelt personal commitment to this cause.

If you’ve been with us for a while or if you have Triple Negative Breast Cancer (TNBC) you know that this subtype is considered more aggressive and has fewer treatment options than other subtypes of breast cancer. By now, you’re also likely aware of the risks associated with TNBC. In 2023, we launched a report that identifies the educational, informational, and support needs of Canadians diagnosed with TNBC. Since then, we’ve dedicated significant time to raising awareness about its findings, including targeted advocacy for improvements in key issues affecting TNBC patients or those who are at elevated risk of developing TNBC.

I wasn’t feeling the hope. Not this morning. My pre-breakfast state of mind was consumed by a knot in my stomach, a persistent sense of anxiety and frustration, and the crappy reality that I really and truly don’t know what I’m doing with my life or what my future holds.

In December 2016, I was diagnosed with Stage III HER2-positive Invasive Ductal Carcinoma, two months after my 39th birthday. It was one of the scariest times of my life. It felt unreal at first and everything became a haze instantly. I never imagined I would hear those words and that they would be talking about me. The next thing I remember is the doctor telling me that they know exactly what to do, and that the survival rate was 88% and I should focus on that. To be honest, most of what she said that day sounded to me like jumbled up words. I allowed myself to cry on the day I was diagnosed but very early on, I decided to only focus on what life would be after cancer.

We know that facing a breast cancer diagnosis is a daunting thing to experience. But for some, the challenges, fears, and uncertainty can be compounded by a lack of access to culturally competent care and tailored supportive resources that truly understand and address the unique needs of diverse community groups. We’ve compiled a non-exhaustive list of resources we know to be helpful and can provide much-needed assurance and support to culturally diverse communities, young women, those with high familial risk and LGBTQ+ individuals.

Fourteen years ago, I got the news that I had cancer. It was in both breasts. My colleagues were there for me all the way. Then, after nine months, my treatment ended, and I went back to work as a family doctor, but things were different. I was fragile. I had a new body. I was living with a newly diagnosed BRCA gene mutation that put me at high risk of breast and ovarian cancer. I required a prophylactic hysterectomy and breast reconstruction, making choices that would impact me and my family. The psychological impact was massive.